Spots Global Cancer Trial Database for neuroendocrine neoplasm

Every month we try and update this database with for neuroendocrine neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm	NCT04927611	Neuroendocrine ...	Biopsy, open or...	18 Years - 80 Years	Fudan University
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors	NCT03001349	Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind...	Computed Tomogr... Gallium Ga 68-E... Positron Emissi...	-	M.D. Anderson Cancer Center
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors	NCT06276309	Neuroendocrine ... China Women Cervical Cancer Cervical Lesion		-	Fujian Maternity and Child Health Hospital
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases	NCT03457948	Metastatic Mali... Neuroendocrine ...	Arterial Emboli... Pembrolizumab Peptide Recepto... Yttrium-90 Micr...	18 Years -	University of California, San Francisco
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers	NCT04459273	Bladder Carcino... Cervical Carcin... Cholangiocarcin... Hematopoietic a... Hepatocellular ... Malignant Adren... Malignant Brain... Malignant Pleur... Malignant Skin ... Malignant Solid... Malignant Testi... Malignant Thymu... Neuroendocrine ... Thyroid Gland C... Urothelial Carc... Cancer of Unkno...	Computed Tomogr... Gallium Ga 68 F... Positron Emissi... 18F-FDG	18 Years -	Jonsson Comprehensive Cancer Center
Project: Every Child for Younger Patients With Cancer	NCT02402244	Carcinoma In Si... Central Nervous... Childhood Immat... Childhood Lange... Childhood Matur... Congenital Meso... Desmoid Fibroma... Ganglioneuroma Lymphoprolifera... Malignant Solid... Melanocytic Neo... Myeloproliferat... Neuroendocrine ... Stromal Neoplas...	Cytology Specim... Medical Chart R...	- 25 Years	Children's Oncology Group
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors	NCT02399215	Carcinoid Tumor Metastatic Carc... Neuroendocrine ...	Laboratory Biom... Nintedanib Pharmacological... Quality-of-Life...	18 Years -	Roswell Park Cancer Institute
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer	NCT02402920	Extensive Stage... Limited Stage S... Neuroendocrine ...	Carboplatin Cisplatin Etoposide Laboratory Biom... Pembrolizumab Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	NCT02831179	Functional Panc... Malignant Somat... Merkel Cell Car... Metastatic Adre... Metastatic Carc... Multiple Endocr... Multiple Endocr... Multiple Endocr... Neuroendocrine ... Non-Functional ... Pancreatic Gluc... Pancreatic Insu... Recurrent Adren... Recurrent Adren... Recurrent Merke... Somatostatin-Pr... Stage III Adren... Stage III Thyro... Stage IIIA Merk... Stage IIIB Merk... Stage IV Adrena... Stage IV Merkel... Stage IVA Thyro... Stage IVB Thyro... Stage IVC Thyro... Thymic Carcinoi... VIP-Producing N... Well Differenti... Zollinger Ellis...	Capecitabine Temozolomide Veliparib Pharmacological... Laboratory Biom...	18 Years -	Vanderbilt-Ingram Cancer Center
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors	NCT03001349	Meningioma Metastatic Well... Multiple Endocr... Neuroendocrine ... Somatostatin Po... Von Hippel-Lind...	Computed Tomogr... Gallium Ga 68-E... Positron Emissi...	-	M.D. Anderson Cancer Center
Project: Every Child for Younger Patients With Cancer	NCT02402244	Carcinoma In Si... Central Nervous... Childhood Immat... Childhood Lange... Childhood Matur... Congenital Meso... Desmoid Fibroma... Ganglioneuroma Lymphoprolifera... Malignant Solid... Melanocytic Neo... Myeloproliferat... Neuroendocrine ... Stromal Neoplas...	Cytology Specim... Medical Chart R...	- 25 Years	Children's Oncology Group
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	NCT00569127	Colorectal Neur... Gastric Neuroen... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ...	Bevacizumab Laboratory Biom... Octreotide Acet... Recombinant Int...	-	National Cancer Institute (NCI)
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm	NCT04927611	Neuroendocrine ...	Biopsy, open or...	18 Years - 80 Years	Fudan University
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	NCT00569127	Colorectal Neur... Gastric Neuroen... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ...	Bevacizumab Laboratory Biom... Octreotide Acet... Recombinant Int...	-	National Cancer Institute (NCI)
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors	NCT03734913	Basal Cell Carc... Medulloblastoma Adenocarcinoma ... Small Cell Lung... Neuroendocrine ... Glioblastoma	ZSP1602	18 Years - 75 Years	Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC	NCT05165407	Neuroendocrine ...	Sintilimab IBI310 Surufatinib	18 Years - 75 Years	Peking University
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging	NCT02817945	Lung Cancer Neuroendocrine ...	68Ga-NOTA-3P-TA...	18 Years - 80 Years	Peking Union Medical College Hospital
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)	NCT04464122	Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ...	Somatostatin an...	18 Years - 80 Years	University of Roma La Sapienza
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors	NCT03950609	Advanced Carcin... Digestive Syste... Multiple Endocr... Neuroendocrine ... Unresectable Ca...	Everolimus Lenvatinib	18 Years -	M.D. Anderson Cancer Center
Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors	NCT04750954	Neuroendocrine ...	Biospecimen Col... Computed Tomogr... Lutetium Lu 177... Magnetic Resona... Peposertib	18 Years -	National Cancer Institute (NCI)
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors	NCT03734913	Basal Cell Carc... Medulloblastoma Adenocarcinoma ... Small Cell Lung... Neuroendocrine ... Glioblastoma	ZSP1602	18 Years - 75 Years	Guangdong Zhongsheng Pharmaceutical Co., Ltd.
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.	NCT06337760	Neuroendocrine ... Adenocarcinoma		18 Years - 39 Years	European Institute of Oncology
Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.	NCT03980925	Neuroendocrine ... Neuroendocrine ... Gastroenteropan...	Nivolumab Carboplatin Etoposide	18 Years -	Grupo Espanol de Tumores Neuroendocrinos
Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)	NCT04720391	Bone Metastases Neuroendocrine ...		-	European Institute of Oncology
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	NCT03375320	Carcinoid Tumor Functioning Pan... Intermediate Gr... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Low Grade Lung ... Lung Neuroendoc... Lung Neuroendoc... Metastatic Dige... Metastatic Dige... Metastatic Lung... Metastatic Lung... Metastatic Panc... Metastatic Panc... Metastatic Thym... Neuroendocrine ... Neuroendocrine ... Non-Functioning... Pancreatic Sero... Thymic Neuroend... Unresectable Di... Unresectable Di... Unresectable Lu... Unresectable Pa... Unresectable Th...	Cabozantinib S-... Computed Tomogr... Magnetic Resona... Placebo Adminis... Quality-of-Life... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)	NCT04464122	Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ...	Somatostatin an...	18 Years - 80 Years	University of Roma La Sapienza
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	NCT02831179	Functional Panc... Malignant Somat... Merkel Cell Car... Metastatic Adre... Metastatic Carc... Multiple Endocr... Multiple Endocr... Multiple Endocr... Neuroendocrine ... Non-Functional ... Pancreatic Gluc... Pancreatic Insu... Recurrent Adren... Recurrent Adren... Recurrent Merke... Somatostatin-Pr... Stage III Adren... Stage III Thyro... Stage IIIA Merk... Stage IIIB Merk... Stage IV Adrena... Stage IV Merkel... Stage IVA Thyro... Stage IVB Thyro... Stage IVC Thyro... Thymic Carcinoi... VIP-Producing N... Well Differenti... Zollinger Ellis...	Capecitabine Temozolomide Veliparib Pharmacological... Laboratory Biom...	18 Years -	Vanderbilt-Ingram Cancer Center
Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients	NCT06343428	Neuroendocrine ...		18 Years -	European Institute of Oncology

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: